Member of Russian Academy of Sciences, Member of Academia Europaea, Head of Molecular Immunology Laboratory, Russia
Dr. Sergey M. Deyev is a distinguished Professor and a full member of the Russian Academy of Sciences. Renowned for his contributions to molecular immunology, Dr. Deyev is currently the Deputy Chairman of the Expert Council for Biology at the Russian Foundation for Basic Research and leads the Molecular Immunology Laboratory at the Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry. His career spans several decades, characterized by groundbreaking research in targeted cancer therapies and nanoparticle applications.
Profile
Scopus
Education 🎓:
Dr. Deyev completed his M.Sc. in Chemistry from Lomonosov Moscow State University in 1973, followed by a Ph.D. in Molecular Biology from the Engelhardt Institute of Molecular Biology in 1977. His Doctor of Science (D.Sc.) in Molecular Biology was awarded in 1990, with his thesis focusing on the structure and rearrangements of immunoglobulin genes.
Experience đź’Ľ:
Dr. Deyev has held prominent roles in academia and research institutions. Since 2000, he has served as the Head of the Molecular Immunology Laboratory at the Shemyakin & Ovchinnikov Institute. He also holds professorships at multiple prestigious institutions, including Lomonosov Moscow State University and the National Research Nuclear University “MEPhI.” His extensive experience includes positions as a visiting professor and researcher internationally, furthering his impact in molecular biology and immunology.
Research Interests 🔬:
Dr. Deyev’s research focuses on developing nanotechnology-based solutions for targeted cancer therapies, including using nanoparticles for diagnostic bioimaging and tumor treatment. His lab specializes in the targeted delivery of nano-agents, high-affinity protein complexes, and genetic engineering of recombinant proteins. He is recognized for discovering the barnase-barstar protein pair, which has applications in drug delivery and immunotherapy.
Awards 🏆:
Throughout his career, Dr. Deyev has received numerous honors, including the prestigious “For Merit to the Fatherland” medal in 2018, the Shemyakin Prize in 2016, and the Mechnikov Prize for contributions to immunology and biotechnology. His membership in Academia Europaea and the Russian Academy of Sciences underscores his significant influence in the scientific community.
Publications Top Notes📚:
Dr. Deyev has co-authored many high-impact research papers, including recent notable publications:
“Flash drug release from nanoparticles accumulated in the targeted blood vessels facilitates the tumour treatment” in Nature Communications (2022) (DOI: 10.1038/s41467-022-34718-3), which has been cited for its contributions to advancing cancer treatment methodologies.
“Switchable targeting of solid tumors by BsCAR T cells” in Proceedings of the National Academy of Sciences USA (2022) (DOI: 10.1073/pnas.2210562119), noted for innovative approaches in T cell-mediated cancer targeting.